عرض بسيط للتسجيلة

المؤلفNaja, Khaled
المؤلفAnwardeen, Najeha
المؤلفMalki, Ahmed M.
المؤلفElrayess, Mohamed A.
تاريخ الإتاحة2024-03-30T08:28:34Z
تاريخ النشر2024-02-02
اسم المنشورFrontiers in Endocrinology
المعرّفhttp://dx.doi.org/10.3389/fendo.2024.1313597
الاقتباسNaja, K., Anwardeen, N., Malki, A. M., & Elrayess, M. A. (2024). Metformin increases 3-hydroxy medium chain fatty acids in patients with type 2 diabetes: a cross-sectional pharmacometabolomic study. Frontiers in Endocrinology, 15, 1313597.
معرّف المصادر الموحدhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85185146069&origin=inward
معرّف المصادر الموحدhttp://hdl.handle.net/10576/53720
الملخصBackground: Metformin is a drug with a long history of providing benefits in diabetes management and beyond. The mechanisms of action of metformin are complex, and continue to be actively debated and investigated. The aim of this study is to identify metabolic signatures associated with metformin treatment, which may explain the pleiotropic mechanisms by which metformin works, and could lead to an improved treatment and expanded use. Methods: This is a cross-sectional study, in which clinical and metabolomic data for 146 patients with type 2 diabetes were retrieved from Qatar Biobank. Patients were categorized into: Metformin-treated, treatment naïve, and non-metformin treated. Orthogonal partial least square discriminate analysis and linear models were used to analyze differences in the level of metabolites between the metformin treated group with each of the other two groups. Results: Patients on metformin therapy showed, among other metabolites, a significant increase in 3-hydroxyoctanoate and 3-hydroxydecanoate, which may have substantial effects on metabolism. Conclusions: This is the first study to report an association between 3-hydroxy medium chain fatty acids with metformin therapy in patients with type 2 diabetes. This opens up new directions towards repurposing metformin by comprehensively understanding the role of these metabolites.
راعي المشروعThe author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by Qatar National Research Fund (QNRF), grant number NPRP13S-1230-190008.
اللغةen
الناشرFrontiers Media SA
الموضوع3-hydroxy medium chain fatty acids
anti-diabetic drugs
metabolomics
metformin
type 2 diabetes
العنوانMetformin increases 3-hydroxy medium chain fatty acids in patients with type 2 diabetes: a cross-sectional pharmacometabolomic study
النوعArticle
رقم المجلد15
ESSN1664-2392
dc.accessType Open Access


الملفات في هذه التسجيلة

Thumbnail

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة